Dornan David has filed 7 insider transactions across 2 companies since February 2024.
Most recent transaction: a grant/award of 282340 shares of Whitehawk Therapeutics, Inc. ($WHWK) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Whitehawk Therapeutics, Inc. | $WHWK | Dornan David | Chief Scientific Officer | A | Stock Option (right to buy) | 282340 | $0.00 | 282,340.0000 | 69,204,899 | 9999.99% | 0.41% |
| March 4, 2025 | Whitehawk Therapeutics, Inc. | $WHWK | Dornan David | Chief Scientific Officer | A | Stock Option (right to buy) | 687979 | $0.00 | 687,979.0000 | 27,029,942 | 9999.99% | 2.55% |
| Feb. 15, 2025 | Elevation Oncology, Inc. | $ELEV | Dornan David | CHIEF SCIENTIFIC OFFICER | M | Restricted Stock Unit | 9375 | $0.00 | 28,125.0000 | 57,275,454 | 25.00% | 0.02% |
| Feb. 15, 2025 | Elevation Oncology, Inc. | $ELEV | Dornan David | CHIEF SCIENTIFIC OFFICER | M | Common Stock | 9375 | $0.00 | 9,375.0000 | 57,275,454 | 9999.99% | 0.02% |
| Feb. 15, 2025 | Elevation Oncology, Inc. | $ELEV | Dornan David | CHIEF SCIENTIFIC OFFICER | F | Common Stock | 4152 | $0.67 | 5,223.0000 | 57,275,454 | 44.29% | 0.01% |
| Feb. 15, 2024 | Elevation Oncology, Inc. | $ELEV | Dornan David | CHIEF SCIENTIFIC OFFICER | A | Stock Option (Right to Buy) | 225000 | $0.00 | 225,000.0000 | 36,522,716 | 9999.99% | 0.62% |
| Feb. 15, 2024 | Elevation Oncology, Inc. | $ELEV | Dornan David | CHIEF SCIENTIFIC OFFICER | A | Restricted Stock Unit | 37500 | $0.00 | 37,500.0000 | 36,522,716 | 9999.99% | 0.10% |